- Q1 2024 DURECT Corp Earnings Call TranscriptMay 13, 2024€0.95 (+1.60%)Earnings
- Q4 2023 DURECT Corp Earnings Call TranscriptMar 27, 2024€1.15 (+1.77%)Earnings
- Q3 2023 DURECT Corp Earnings Call TranscriptNov 13, 2023Earnings
- DURECT Corp Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol TranscriptNov 07, 2023
- DURECT Corp at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Q2 2023 DURECT Corp Earnings Call TranscriptAug 09, 2023€2.82 (-0.70%)Earnings
- Q1 2023 DURECT Corp Earnings Call TranscriptMay 08, 2023€4.3 (+10.82%)Earnings
- DURECT Corp at H.C. Wainwright BioConnect Investor Conference TranscriptMay 02, 2023
- DURECT Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2023
- Q4 2022 DURECT Corp Earnings Call TranscriptMar 07, 2023€4.56 (+2.24%)Earnings
- Q3 2022 DURECT Corp Earnings Call TranscriptNov 02, 2022€6.15 (-1.60%)Earnings
- Q2 2022 DURECT Corp Earnings Call TranscriptAug 04, 2022€5.7 (+8.57%)Earnings
- DURECT Corp Annual Shareholders Meeting TranscriptJun 15, 2022
- Q1 2022 DURECT Corp Earnings Call TranscriptMay 04, 2022€4.06 (+2.01%)Earnings
- Q4 2021 DURECT Corp Earnings Call TranscriptMar 07, 2022€5.6 (-3.45%)Earnings
- DURECT Corp To Discuss Agreement Call TranscriptDec 22, 2021
- Q3 2021 DURECT Corp Earnings Call TranscriptNov 02, 2021€10.9Earnings
- DURECT Corp at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 12, 2021
- Q2 2021 DURECT Corp Earnings Call TranscriptJul 29, 2021€11.8 (+2.61%)Earnings
- DURECT Corp Annual Shareholders Meeting TranscriptJun 15, 2021
- Q1 2021 DURECT Corp Earnings Call TranscriptMay 04, 2021€15.6 (-1.27%)Earnings
- Q4 2020 DURECT Corp Earnings Call TranscriptMar 04, 2021€17.6 (-7.85%)Earnings
- DURECT Corporation - Special Call TranscriptFeb 02, 2021
- DURECT Corporation - Special Call TranscriptNov 20, 2020
- Q3 2020 DURECT Corp Earnings Call TranscriptNov 02, 2020€15.4 (-0.65%)Earnings
- DURECT Corporation - Special Call TranscriptAug 27, 2020
- DURECT Corp DURECT Corporation Summary TranscriptAug 06, 2020
- Q2 2020 DURECT Corp Earnings Call TranscriptAug 03, 2020€17.2 (-1.15%)Earnings
- DURECT Corp Annual Shareholders Meeting TranscriptJun 17, 2020
- Q1 2020 DURECT Corp Earnings Call TranscriptMay 11, 2020€21 (+8.81%)Earnings
- Q4 2019 DURECT Corp Earnings Call TranscriptMar 03, 2020€17.5 (+6.71%)Earnings
- DURECT Corporation - Special Call TranscriptNov 12, 2019
- Q3 2019 DURECT Corp Earnings Call TranscriptNov 04, 2019€17 (+4.94%)Earnings
- Q2 2019 DURECT Corp Earnings Call TranscriptAug 01, 2019€9.64 (+0.88%)Earnings
- Q1 2019 DURECT Corp Earnings Call TranscriptMay 08, 2019€6.56 (-4.29%)Earnings
- DURECT Corporation Key Opinion Leader Call on NASH TranscriptApr 17, 2019
- DURECT Corporation Key Opinion Leader Call on Psoriasis TranscriptMar 29, 2019
- Q4 2018 DURECT Corp Earnings Call TranscriptMar 07, 2019€6.3 (-6.25%)Earnings
- DURECT Corporation - Special Call TranscriptFeb 27, 2019
DURECT Corporation Key Opinion Leader Call on Psoriasis Transcript
Good day, and welcome to the Key Opinion Leader Call on Psoriasis hosted by DURECT Corporation. (Operator Instructions) At this time, I would like turn the conference over to Mr. Mike Arenberg, Chief Financial Officer of DURECT Corporation. Please go ahead.
Welcome to our Key Opinion Leader Call on Psoriasis. This is Mike Arenberg, Chief Financial Officer of DURECT Corporation. This call will begin with a presentation by Dr. Howard Maibach on psoriasis, including an overview of the disease, current treatment options and the treatment landscape for psoriasis. This will be followed by a presentation by Jim Brown, DURECT's President and CEO, on our Phase IIa study on psoriasis with DUR-928, followed by a Q&A session.
Before beginning, I would like to remind you of our safe harbor statement. During the course of this call, we may make forward-looking statements regarding DURECT's business and DUR-928. These forward-looking statements involve risks and uncertainties that can cause actual results to differ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)